Type 2 Diabetes

Posted on 17 Sep 2017
By rb_ad

Current Type 2 Diabetes Studies:

Eli Lilly ITSW

This is a study of LY900014 in participants with Type 2 Diabetes using Continuous Glucose Monitoring.

Learn More

SURPASS-6

This trial compares the efficacy and safety of tirzepatide once weekly at either 5 mg, 10 mg, 15 mg dose to 3 times a day Lispro in patients with type 2 diabetes on glargine.

Learn More

Eli Lilly BDCL

The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes.

Learn More

Semaglutide

The purpose of this study is to evaluate type 2 diabetes medicine, semaglutide, if it has a positive effect on heart disease.

Learn More

RLM-MD Study

A 52-week study that compares the efficacy of Relamorelin with that of placebo in participants with diabetic gastroparesis with respect to the core signs and symptoms of diabetic gastroparesis (RLM-MD).

Learn More

Can’t find a study that works for you?

Click Here